These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2177683)

  • 21. Novel 1',1'-chain substituted Delta(8)-tetrahydrocannabinols.
    Papahatjis DP; Nikas SP; Andreou T; Makriyannis A
    Bioorg Med Chem Lett; 2002 Dec; 12(24):3583-6. PubMed ID: 12443781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A major metabolite of delta 1-tetrahydrocannabinol reduces its cataleptic effect in mice.
    Burstein S; Hunter SA; Latham V; Renzulli L
    Experientia; 1987 Apr; 43(4):402-3. PubMed ID: 3032669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and pharmacological activity of some 9-substituted delta 8-tetrahydrocannabinol analogues.
    Robertson LR; Duffley RP; Razdan RK; Martin BR; Harris LS; Dewey WL
    J Med Chem; 1984 Apr; 27(4):550-2. PubMed ID: 6323713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutralization of the effect of delta 9-tetrahydrocannabinol on barbiturate sleeping time by specific active immunization.
    Giusti GV; Chiarotti M; Vigevani F
    Drug Alcohol Depend; 1980 Mar; 5(3):185-7. PubMed ID: 6243536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypothermic action of delta 9-tetrahydrocannabinol, 11-hydroxy-delta 9-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice.
    Haavik CO; Hardman HF
    Life Sci; 1973 Dec; 13(12):1771-8. PubMed ID: 4777336
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of repeated administration of 11-hydroxy-delta 8-tetrahydrocannabinol, an active metabolite of delta 8-tetrahydrocannabinol, on the hepatic microsomal drug-metabolizing enzyme system of mice.
    Watanabe K; Arai M; Narimatsu S; Yamamoto I; Yoshimura H
    Biochem Pharmacol; 1986 Jun; 35(11):1861-5. PubMed ID: 3013200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Separation and analysis of delta 9-tetrahydrocannabinol in biological fluids by high-pressure liquid chromatography and GLC.
    Garrett ER; Hunt CA
    J Pharm Sci; 1977 Jan; 66(1):20-6. PubMed ID: 833737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacology of some synthetic tetrahydrocannabinols.
    Pradhan SN
    Neurosci Biobehav Rev; 1984; 8(3):369-85. PubMed ID: 6095152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereospecific effects of (-)- and (+)-7-hydroxy-delta-6-tetrahydrocannabinol-dimethylheptyl on the immune system of mice.
    Titishov N; Mechoulam R; Zimmerman AM
    Pharmacology; 1989; 39(6):337-49. PubMed ID: 2561381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mass spectra of the trimethylsilyl derivatives of the hydroxy and acid metabolites of delta 1- and delta 6-tetrahydrocannabinol.
    Harvey DJ
    Biomed Mass Spectrom; 1981 Dec; 8(12):579-88. PubMed ID: 6275928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for a bidirectional cross-tolerance between morphine and delta 9-tetrahydrocannabinol in mice.
    Thorat SN; Bhargava HN
    Eur J Pharmacol; 1994 Jul; 260(1):5-13. PubMed ID: 7957626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoid pharmacological properties common to other centrally acting drugs.
    Wiley JL; Martin BR
    Eur J Pharmacol; 2003 Jun; 471(3):185-93. PubMed ID: 12826237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa.
    Radwan MM; ElSohly MA; El-Alfy AT; Ahmed SA; Slade D; Husni AS; Manly SP; Wilson L; Seale S; Cutler SJ; Ross SA
    J Nat Prod; 2015 Jun; 78(6):1271-6. PubMed ID: 26000707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice.
    Wiley JL; Marusich JA; Lefever TW; Antonazzo KR; Wallgren MT; Cortes RA; Patel PR; Grabenauer M; Moore KN; Thomas BF
    J Pharmacol Exp Ther; 2015 Sep; 354(3):328-39. PubMed ID: 26105953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandins and cannabis--XVI. Antagonism of delta 1-tetrahydrocannabinol action by its metabolites.
    Burstein S; Hunter SA; Latham V; Renzulli L
    Biochem Pharmacol; 1986 Aug; 35(15):2553-8. PubMed ID: 3017356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variation of the alkyl side chain in delta 8-THC.
    Huffman JW; Lainton JA; Dai D; Jordan RD; Duncan SG
    Life Sci; 1995; 56(23-24):2021-4. PubMed ID: 7776827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Confirmation of cannabis use. II. Determination of tetrahydrocannabinol metabolites in urine and plasma by HPLC with ECD.
    Nakahara Y; Sekine H; Cook CE
    J Anal Toxicol; 1989; 13(1):22-4. PubMed ID: 2540383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spinal mechanisms of delta 9-tetrahydrocannabinol-induced analgesia.
    Smith PB; Martin BR
    Brain Res; 1992 Apr; 578(1-2):8-12. PubMed ID: 1324767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex-dependent effects of delta 9-tetrahydrocannabinol on locomotor activity in mice.
    Wiley JL
    Neurosci Lett; 2003 Dec; 352(2):77-80. PubMed ID: 14625027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice.
    Smith PB; Welch SP; Martin BR
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1381-7. PubMed ID: 8138952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.